EMEA-000479-PIP01-08-M03

Key facts

Invented name
Ryzodeg
Active substance
  • insulin degludec
  • insulin aspart
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0034/2015
PIP number
EMEA-000479-PIP01-08-M03
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Treatment of type I diabetes mellitus
  • Treatment of type II diabetes mellitus
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Novo Nordisk A/S
Denmark
Tel. +45 3075 8242
Fax +45 3969 9173
E-mail: de@novonordisk.com
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000479-PIP01-08-M03
Compliance opinion date
11/09/2015
Compliance outcome
positive

Decision

How useful was this page?

Add your rating
Average
1 rating